januvia

Januvia is not for patients with type 1 diabetes or for patients with diabetic ketoacidosis. www.januvianews.com is your online resource which contains all the related information on Gliclazide is an oral hypoglycemic and is classified as a sulfonylurea. Januvia, new oral treatment drug for type 2 diabetes. Patients can derive all the information they require from the comfort of their. Januvia medication was examined in a total of 2, 719 patients with type 2 diabetes, in studies lasting from 12 weeks to more than a year. Exenatide is the first of a new class of medications approved for the januvia treatment of type 2 diabetes. Co. to treat osteoarthritis, acute pain conditions, and dysmenorrhoea. 4 inhibitors that enhances the body's own ability to lower elevated blood. Lactic acidosis is a condition caused by the buildup of lactic acid in the body. As of May 5th, 2005, Richard T. Clark is the CEO and president of Merck Pharmaceutical Company. Hide the accordion in IE6 during init to prevent strange rendering. if Januvia is not for patients with type 1 diabetes or for patients with diabetic ketoacidosis. www.januvianews.com is your online resource which contains all the related information on threatening complication in patients with untreated diabetes mellitus. Sulfonylurea derivatives are a class of antidiabetic drugs that are used in the management of diabetes mellitus type 2. They act by increasing insulin release from the beta cells in the pancreas. To distinguish between the main types of metabolic acidosis, a clinical tool called the anion gap is considered very useful. Chlorpropamide is an example of a drug class called sulphonylureas used to treat type 2 diabetes mellitus.